Roivant Sciences Ltd.

ISIN BMG762791017

 | 

WKN A3C4MS

Market cap (in EUR)
22,476 m
Country
United Kingdom
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Show more Show less
Healthcare Healthcare Services Miscellaneous Healthcare United Kingdom

Financials

Key metrics

Market capitalisation, EUR 22,476 m
EPS, EUR -0.38
P/B ratio 6.2
P/E ratio 1.9
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 7 m
Net income, EUR -259 m
Profit margin -3,629.19%

What ETF is Roivant Sciences Ltd. in?

There are 19 ETFs which contain Roivant Sciences Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Roivant Sciences Ltd. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI World UCITS ETF (Dist) 0.02%
Equity
World
8,515
Amundi MSCI World Swap II UCITS ETF Dist 0.02%
Equity
World
9,014
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.05%
Equity
World
Health Care
Social/Environmental
750
iShares MSCI All Country World UCITS ETF USD (Acc) 0.00%
Equity
World
31,796
iShares MSCI USA Screened UCITS ETF USD (Dist) 0.03%
Equity
United States
Social/Environmental
1,498
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.02%
Equity
World
Social/Environmental
570
Goldman Sachs Alpha Enhanced US Equity Active UCITS ETF USD (Dist) 0.09%
Equity
United States
Social/Environmental
0
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.24%
Equity
United States
Small Cap
231
Vanguard FTSE Global All-Cap UCITS ETF USD Dist 0.01%
Equity
World
115
iShares MSCI USA CTB Enhanced ESG UCITS ETF USD (Dist) 0.07%
Equity
United States
Social/Environmental
16,718
Goldman Sachs Alpha Enhanced US Equity Active UCITS ETF USD (Acc) 0.09%
Equity
United States
Social/Environmental
340
iShares MSCI North America UCITS ETF 0.03%
Equity
North America
1,433
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.61%
Equity
United States
Health Care
Biotech
72
Vanguard FTSE Global Small-Cap UCITS ETF USD Dist 0.15%
Equity
World
Small Cap
11
Vanguard Russell 1000 U.S. Value UCITS ETF USD Dist 0.05%
Equity
United States
Value
1
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.03%
Equity
North America
Social/Environmental
30
iShares MSCI World Screened UCITS ETF USD (Dist) 0.02%
Equity
World
Social/Environmental
1,022
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist 0.12%
Equity
United States
Mid Cap
3
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist) 0.10%
Equity
United States
Momentum
14
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.